Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/01/01
-
Journal
-
Indian UGC (journal)
-
Refrences99
-
Citations55
-
Baby Santosh Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India ORCID
-
Pramod K. Yadava Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India
Abstract
Cite
Santosh, Baby, and Pramod K. Yadava. “Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics”. BioMed Research International, vol. 2014, 2014, pp. 1-13, https://doi.org/10.1155/2014/540451.
Santosh, B., & Yadava, P. K. (2014). Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics. BioMed Research International, 2014, 1-13. https://doi.org/10.1155/2014/540451
Santosh, Baby, and Pramod K. Yadava. “Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics”. BioMed Research International 2014 (2014): 1-13. https://doi.org/10.1155/2014/540451.
Santosh B, Yadava PK. Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics. BioMed Research International. 2014;2014:1-13.
Journal Categories
Medicine
Medicine (General)
Technology
Chemical technology
Biotechnology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Regado's aptamer lines up against anticoagulants | Nature Biotechnology |
| 4 | 2013 |
Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia | Blood Journal |
| 38 | 2011 |
Use of Magnetic Beads in Selection and Detection of Biotoxin Aptamers by Electrochemiluminescence and Enzymatic Methods | BioTechniques |
| 112 | 2002 |
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics | Clinical Chemistry |
| 1,466 | 1999 |
| Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics | 2013 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy | Critical Reviews™ in Therapeutic Drug Carrier Systems |
| 2024 | |
| Analysis on the in-silico ensemble methods for 3D modelling of ssDNA aptamers | Biophysical Chemistry |
| 1 | 2023 |
| Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery | Biomaterials Research |
| 8 | 2023 |
Moving towards Personalized Medicine—The Broad Use of Aptamers for Targeted Theranostic | Applied Sciences |
| 2023 | |
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors | Cancers |
| 5 | 2023 |
Citations Analysis
The category
Science: Biology (General) 27
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Alternatives to Antibiotics in Animal Agriculture: An Ecoimmunological View and was published in 2014. The most recent citation comes from a 2024 study titled A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy. This article reached its peak citation in 2021, with 10 citations. It has been cited in 44 different journals, 25% of which are open access. Among related journals, the Molecules cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.